Bones of Contention: Comparative Analysis of Osteosarcoma and Ewing's Sarcoma
Availability
On-Demand
Cost
Member: $30.00
Non-Member: $40.00
Credit Offered
1 NCPD Credit
Meghan Harris MSN, APRN-NP, CPNP-AC  
Yael Derman MSN, APRN, CPNP-AC, CPHON

This session will explore how osteosarcoma and Ewing’s sarcoma are the two most common primary malignant bone tumors in children and young adults, yet they exhibit distinct clinical, radiographic, histologic, and genetic characteristics. This lecture will provide a comparative analysis of these tumors, beginning with their typical age of onset, staging at presentation, and key diagnostic features. We will explore imaging modalities and histo-pathologic findings that aid in differentiation, along with a review of their genetic profiles, including implications for hereditary cancer syndromes such as Li-Fraumeni. Treatment strategies will be discussed, covering multimodal approaches such as chemotherapy, surgical resection, and radiation therapy. Lastly, we will examine patient outcomes, highlighting morbidity, mortality, and advancements in therapeutic protocols.

This contains 2 sections:

  1.  Video Presentation
  2.  Reflection Questions
  3. Post-Session Evaluation
  • Learners will be able to self-report increased ability to differentiate osteosarcoma vs. Ewing sarcoma according to age, stage, histologic, genetic, and radiographic features as well as treatment regimens. 

  • Learners will self-report an increase in confidence when caring for a patient with osteosarcoma and Ewing sarcoma 

APHON will providenursing continuing professional development (NCPD) contact hour(s) for the successful completion of this session. Successful completion requires attendance for the entire session and completion of the post-session evaluation. 

The Association for Pediatric Hematology Oncology Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. This provider is also approved by the California Board of Registered Nursing, Provider Number 14513. 

None of the planners for this activity have relevant financial relationship(s) to disclose with ineligible companies. 

This program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points. You may claim 1 ILNA in one of the following categories:  

  • Disease Related Biology
  • Pediatric Hem/Onc Nursing Practice
  • Care of the Peds Hem/Onc Patient
  • Treatment

Questions or concerns? Contact education@aphon.org.